Identification of antigen epitopes and immune sequences recognizing the antigens

Patent metadata

Field	Value
Publication number	US-10168328-B2
Application number	US-201615216527-A
Country	US
Kind code	B2
Filing date	Jul 21, 2016
Priority date	Jul 22, 2015
Publication date	Jan 1, 2019
Grant date	Jan 1, 2019

Abstract

Methods, compositions, and reaction mixtures are provided for identifying a T cell receptor (TCR) and an epitope peptide that specifically binds the TCR. Methods, compositions, and reaction mixtures are also provided for identifying a plurality of T cell receptors and corresponding epitope peptides that specifically bind the T cell receptors. In some cases, the plurality of T cell receptors and corresponding epitope peptides can be identified in a highly parallel manner.

First claim

What is claimed is:

1. A method for identifying a T cell receptor (TCR) and an epitope peptide that specifically binds the TCR, the method comprising:
a) providing a plurality of mixture partitions comprising a population of T cells, the T cells comprising a plurality of different TCRs having a TCR heavy chain encoded by a TCR heavy chain nucleic acid and a TCR light chain encoded by a TCR light chain nucleic acid, wherein individual mixture partitions of the plurality of mixture partitions comprise:
i) a portion of the population of T cells, wherein the portion of T cells comprises one or more TCRs that specifically bind to a portion of a plurality of epitope peptides present in the mixture partition;
ii) a plurality of partition-specific barcodes comprising nucleic acid sequence capable of identifying the partition; and
iii) a plurality of epitope nucleic acids encoding the epitope peptides;

b) in the plurality of mixture partitions, generating barcoded nucleic acids by attaching the partition-specific barcodes to the TCR heavy chain, TCR light chain, and epitope nucleic acids;
c) pooling the barcoded nucleic acids to form a pooled mixture; and
d) sequencing the barcoded nucleic acids in the pooled mixture and thereby identifying the sequence of the heavy and light chain of the TCR that specifically binds the epitope peptide and the sequence of the epitope peptide that specifically binds the TCR by identifying heavy and light chain nucleic acids and epitope nucleic acids having matching partition-specific barcodes.

2. The method of claim 1 , wherein the method further comprises:
e) determining a partition segregation pattern for a plurality of TCR heavy chains, TCR light chains, and epitope peptides by identifying TCR heavy chain nucleic acids that have identical protein coding sequences but different partition-specific barcodes, TCR light chain nucleic acids that have identical protein coding sequences but different partition-specific barcodes, and epitope nucleic acids that have identical protein coding sequences but different partition-specific barcodes;
f) classifying TCR heavy chain, TCR light chain, and epitope nucleic acids that co-segregate in a larger number of partitions than expected by chance as encoding a TCR and epitope peptide that specifically bind to each other, wherein the random chance co-segregation of TCR heavy chain, TCR light chain, and epitope nucleic acids is calculated as (1/N) 3 , wherein N is the number of partitions.

3. The method of claim 2 , wherein at least one subpopulation of the T cells comprise TCRs having identical TCR heavy chain and TCR light chain nucleic acid sequences.

4. The method of claim 1 , wherein the plurality of mixture partitions is a plurality of single cell mixture partitions, and wherein the method comprises classifying barcoded TCR heavy chain, TCR light chain, and epitope nucleic acids that have the same barcode as encoding the TCR and the epitope peptide that specifically binds the TCR.

5. The method of claim 1 , wherein the providing of claim 1 a) comprises partitioning (T cell):(epitope peptide) complexes into the plurality of mixture partitions in the presence of the plurality of partition-specific barcodes under conditions such that all or substantially all mixture partitions contain no more than one partition-specific barcode sequence.

6. The method of claim 1 , wherein the providing of claim 1 a) comprises partitioning (T cell):(epitope peptide) complexes into the plurality of mixture partitions such that all or substantially all mixture partitions contain a different partition-specific barcode sequence, if present.

7. The method of claim 1 , wherein the providing of claim 1 a) comprises partitioning (T cell):(epitope peptide) complexes into the plurality of mixture partitions and then introducing into the mixture partitions the partition-specific barcode nucleic acids.

8. The method of claim 1 , wherein the plurality of epitope nucleic acids are immobilized on a plurality of solid supports, such that each solid support has a clonal population of immobilized epitope nucleic acids.

9. The method of claim 8 , wherein the plurality of epitope peptides are immobilized on the plurality of solid supports, such that each solid support has a clonal population of immobilized epitope peptides.

10. The method of claim 9 , wherein the clonal population of epitope nucleic acids immobilized on each solid support encodes the clonal population of epitope peptides immobilized on that same solid support.

11. The method of claim 10 , wherein the epitope peptide nucleic acids further encode a β2-microglobulin peptide fused to the epitope peptide.

12. The method of claim 11 , wherein the epitope peptide is displayed in the context of a major histocompatibility complex class I (MHC class I) protein comprising the (β2-microglobulin peptide and an MHC class I heavy chain.

13. The method of claim 12 , wherein the epitope peptides displayed in the context of the MHC class I protein are provided by:
a) partitioning a library of solid surface immobilized epitope nucleic acids encoding the epitope peptide fused to the β2-microglobulin peptide and a first binding member peptide, wherein the first binding member peptide has affinity for a second binding member immobilized on the solid surface, and wherein each solid surface comprises a clonal population of immobilized epitope nucleic acids;
b) in vitro transcribing and translating the immobilized epitope nucleic acids in the partitions, thereby generating a library of solid surface immobilized epitope peptides, wherein each solid surface comprises a clonal population of epitope peptides fused to β2-microglobulin peptides and first binding member peptides bound to the second binding member, and wherein each solid surface comprises a clonal population of immobilized epitope nucleic acids that encode the immobilized epitope peptides; and
c) refolding the epitope peptides in the presence of MHC class I heavy chain.

14. The method of claim 13 , wherein the refolding is performed in the partitions.

15. The method of claim 13 , wherein the partitions are combined prior to refolding, and wherein the refolding is performed under conditions that do not disrupt the binding between the first and second binding members.

16. The method of claim 13 , wherein the first and second binding members are independently selected from the group consisting of streptavidin and streptavidin binding protein.

17. The method of claim 12 , wherein prior to the providing of claim 1 a), the method comprises contacting the MHC class I displayed epitope peptides with the population of T cells to generate a mixture containing a population of T cells comprising (TCR):(MHC class I displayed epitope peptide) complexes.

18. The method of claim 17 , wherein the mixture containing the population of T cells comprising (TCR):(MHC class I displayed epitope peptide) complexes is filtered to remove non-specifically bound and unbound MHC class I displayed epitope peptides if present.

19. The method of claim 1 , wherein the method further comprises confirming binding between the TCR and epitope peptide by contacting the TCR with the epitope peptide that specifically binds the TCR.

20. The method of claim 19 , wherein the epitope peptide is displayed in the context of an MHC class I molecule.

21. The method of claim 19 , wherein the method further comprises detecting the binding by a method selected from ELISA, mass spectrometry and flow cytometry.

Assignees

• Roche Molecular Systems Inc
• Roche Sequencing Solutions Inc

Inventors

• Berka Jan

Classifications

• C12Q2563/179

  the label being a nucleic acid · CPC title

• C12Q2565/514

  characterised by the use of the arrayed oligonucleotides as identifier tags, e.g. universal addressable array, anti-tag or tag complement array · CPC title

• C12Q2535/122

  Massive parallel sequencing · CPC title

• C12Q2525/161

  incorporating target specific and non-target specific sites · CPC title

• C12Q1/6846 Primary

  Common amplification features · CPC title